- Home
- ZNTL vs TONX Comparison
ZNTL vs TONX Comparison
Compare ZNTL & TONX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | TONX |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.5M | 136.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZNTL | TONX |
|---|---|---|
| Price | $2.50 | $2.07 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 467.8K |
| Earning Date | 03-25-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 7.29 |
| Revenue | ★ $26,865,000.00 | $7,760,000.00 |
| Revenue This Year | N/A | $526.82 |
| Revenue Next Year | N/A | $45.45 |
| P/E Ratio | ★ N/A | $0.28 |
| Revenue Growth | N/A | ★ 3760.70 |
| 52 Week Low | $1.01 | $1.78 |
| 52 Week High | $3.95 | $29.77 |
Technical Indicators
Market Signals| Indicator | ZNTL | TONX |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 36.61 |
| Support Level | $2.21 | $1.78 |
| Resistance Level | $2.85 | $2.06 |
| Average True Range (ATR) | 0.29 | 0.22 |
| MACD | -0.09 | -0.05 |
| Stochastic Oscillator | 25.93 | 25.12 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About TONX TON Strategy Company
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.